• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bioavailability and antagonization of the low molecular weight heparin CY 216 in man.

作者信息

Harenberg J, Würzner B, Zimmermann R, Schettler G

出版信息

Thromb Res. 1986 Nov 15;44(4):549-54. doi: 10.1016/0049-3848(86)90333-6.

DOI:10.1016/0049-3848(86)90333-6
PMID:3798415
Abstract
摘要

相似文献

1
Bioavailability and antagonization of the low molecular weight heparin CY 216 in man.
Thromb Res. 1986 Nov 15;44(4):549-54. doi: 10.1016/0049-3848(86)90333-6.
2
In vivo attempt to consume antithrombin III by i.v. injection of a thrombin-heparin mixture.通过静脉注射凝血酶 - 肝素混合物在体内消耗抗凝血酶III的尝试。
Thromb Res. 1984 May 1;34(3):255-62. doi: 10.1016/0049-3848(84)90009-4.
3
Prophylactic use of antithrombin III for protection of haemostatic balance in patients undergoing cardiopulmonary bypass.
J Cardiothorac Anesth. 1989 Oct;3(5 Suppl 1):87. doi: 10.1016/0888-6296(89)90830-2.
4
Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.关于鱼精蛋白对人凝血系统激活部位的普通肝素和低分子量肝素（速避凝）的中和作用的研究。
Thromb Haemost. 1995 Mar;73(3):439-43.
5
In-vitro and ex-vivo neutralizing effect of protamine sulphate on the anticoagulant activity of a new low molecular mass heparin.硫酸鱼精蛋白对一种新型低分子质量肝素抗凝活性的体外及离体中和作用
Thromb Res. 1998 Jan 15;89(2):79-83. doi: 10.1016/s0049-3848(97)00294-6.
6
[Protamine complexes with antithrombin III and heparin].
Acta Haematol Pol. 1982 Jan-Jun;13(1-2):25-8.
7
Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation.凝血系统的激活：用于体外循环的肝素涂层与非涂层系统
Int J Artif Organs. 1997 Dec;20(12):708-12.
8
Effect of protamine on heparin-antithrombin III complexes. In vitro studies.
Thromb Res. 1980;17(3-4):367-74. doi: 10.1016/0049-3848(80)90071-7.
9
[In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].[鱼精蛋白对低分子量肝素组分CY 216的体外和体内中和作用]
Ann Pharm Fr. 1986;44(1):65-72.
10
[Mechanisms of heparin resistance and their clinical significance].[肝素抵抗的机制及其临床意义]
Ter Arkh. 1982;54(8):77-82.

引用本文的文献

1
The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin.危重症患者中测量抗Xa活性的最佳时机：治疗剂量那屈肝素的药代动力学
Res Pract Thromb Haemost. 2023 May 20;7(4):100185. doi: 10.1016/j.rpth.2023.100185. eCollection 2023 May.
2
Functionally integrating nanoparticles alleviate deep vein thrombosis in pregnancy and rescue intrauterine growth restriction.功能整合纳米粒子可减轻妊娠深静脉血栓形成并挽救宫内生长受限。
Nat Commun. 2022 Nov 22;13(1):7166. doi: 10.1038/s41467-022-34878-2.
3
Inhibition of platelet-surface-bound proteins during coagulation under flow II: Antithrombin and heparin.
在流动条件下抑制血小板表面结合蛋白Ⅱ：抗凝血酶和肝素。
Biophys J. 2023 Jan 3;122(1):230-240. doi: 10.1016/j.bpj.2022.10.038. Epub 2022 Nov 2.
4
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.新生儿和儿童的抗血栓治疗：抗血栓治疗和血栓预防，第 9 版：美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308.
5
Anti-Xa Levels 4 h After Subcutaneous Administration of 5,700 IU Nadroparin Strongly Correlate with Lean Body Weight in Morbidly Obese Patients.病态肥胖患者皮下注射5700 IU那屈肝素4小时后的抗Xa水平与瘦体重密切相关。
Obes Surg. 2012 Feb 1. doi: 10.1007/s11695-012-0602-7.
6
Comparative effectiveness of several agents for preventing postoperative adhesions.几种预防术后粘连药物的比较疗效
World J Surg. 2004 Jul;28(7):662-5. doi: 10.1007/s00268-004-6825-6. Epub 2004 Jun 8.
7
Low molecular weight heparins: a guide to their optimum use in pregnancy.低分子量肝素：孕期最佳使用指南。
Drugs. 2002;62(3):463-77. doi: 10.2165/00003495-200262030-00004.
8
Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonists in renal failure.低分子量肝素和糖蛋白IIb/IIIa受体拮抗剂在肾衰竭中的药代动力学和药效学
J Thromb Thrombolysis. 2001 Feb;11(1):39-48. doi: 10.1023/a:1008904310194.
9
Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin.低分子量肝素治疗静脉血栓栓塞症
J Thromb Thrombolysis. 1995;1(3):279-284. doi: 10.1007/BF01060737.
10
Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.那屈肝素钙。其药理学及在预防和治疗血栓栓塞性疾病中的临床应用综述。
Drugs Aging. 1997 Apr;10(4):299-322. doi: 10.2165/00002512-199710040-00006.